143 related articles for article (PubMed ID: 1259412)
41. Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex.
Sammons ML; Stephen EL; Levy HB; Baron S; Hilmas DE
Antimicrob Agents Chemother; 1977 Jan; 11(1):80-3. PubMed ID: 402107
[TBL] [Abstract][Full Text] [Related]
42. Interferon production of L929 and HeLa cells enhanced by polyriboinosinic acid-polyribocytidylic acid pH-sensitive liposomes.
Milhaud PG; Compagnon B; Bienvenüe A; Philippot JR
Bioconjug Chem; 1992; 3(5):402-7. PubMed ID: 1384719
[TBL] [Abstract][Full Text] [Related]
43. Interferon production linked to toxicity of polyriboinosinic acid-polyribocytidylic acid.
De Clercq E; Stewart WE; De Somer P
Infect Immun; 1972 Sep; 6(3):344-7. PubMed ID: 4564891
[TBL] [Abstract][Full Text] [Related]
44. Protective and toxic effects of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid on Venezuelan equine encephalomyelitis virus in rhesus monkeys.
Stephen EL; Hilmas DE; Levy HB; Spertzel RO
J Infect Dis; 1979 Mar; 139(3):267-72. PubMed ID: 109544
[TBL] [Abstract][Full Text] [Related]
45. Macrophage dependence of polyriboinosinic acid-polyribocytidylic acid-induced resistance to herpes simplex virus infection in mice.
Martinez D; Lynch RJ; Meeker JB; Field AK
Infect Immun; 1980 Apr; 28(1):147-53. PubMed ID: 6155345
[TBL] [Abstract][Full Text] [Related]
46. Interferon-inducer polyriboinosinic-polyribocytidylic acid: a potent anti-gastric ulcer agent and inhibitor of the gastric proton pump in rats.
Nath C; Rastogi L; Dikshit M; Patnaik GK; Saxena RC; Gupta MB
Clin Exp Pharmacol Physiol; 1998; 25(7-8):564-7. PubMed ID: 9673429
[TBL] [Abstract][Full Text] [Related]
47. Repeated 'superinduction' of interferon in human diploid fibroblast cultures.
Wiranowska-Stewart M; Chudzio T; Stewart WE
J Gen Virol; 1977 Oct; 37(1):221-3. PubMed ID: 915483
[TBL] [Abstract][Full Text] [Related]
48. Relationship of cytotoxicity and interferon-inducing activity of polyriboinosinic acid. Polyribocytidylic acid to the molecular weights of the homopolymers.
Stewart WE; De Clercq E
J Gen Virol; 1974 Apr; 23(1):83-9. PubMed ID: 4833602
[No Abstract] [Full Text] [Related]
49. Chronic induction of interferon by continuous infusion of polyriboinosinic:polyribocytidilic acid.
Rothmann SA; Paul P; Oluic' TJ; Sturkie KA; Proffitt MR
J Interferon Res; 1985; 5(2):273-8. PubMed ID: 2409189
[TBL] [Abstract][Full Text] [Related]
50. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).
Medoff G; Kobayashi GS; Kwan CN; Schlessinger D; Venkov P
Proc Natl Acad Sci U S A; 1972 Jan; 69(1):196-9. PubMed ID: 4550505
[TBL] [Abstract][Full Text] [Related]
51. Effect of thymosin fraction 5 on the production of murine gamma interferon.
Sonnenfeld G; Mansfield JM
Immunopharmacology; 1982 Feb; 4(1):87-93. PubMed ID: 6174479
[TBL] [Abstract][Full Text] [Related]
52. The effect of hypertonic salt on interferon and interferon mRNA synthesis in human MG63 cells.
Meager A; Shuttleworth J; Just MD; Boseley P; Morser J
J Gen Virol; 1982 Mar; 59(Pt 1):177-81. PubMed ID: 6175728
[TBL] [Abstract][Full Text] [Related]
53. Molecular structure of human fibroblast and leukocyte interferons: probe by lectin and hydrophobic chromatography.
Jankowski WJ; Davey MW; O'Malley JA; Sulkowski E; Carter WA
J Virol; 1975 Nov; 16(5):1124-30. PubMed ID: 1185850
[TBL] [Abstract][Full Text] [Related]
54. Interferon production and resistance to viral infection induced by poly I-poly C in chick embryo cells. II. Lack of enhancement by DEAE-dextran.
Machida H; Kuninaka A; Yoshino H
Jpn J Microbiol; 1975 Feb; 19(1):65-8. PubMed ID: 169418
[No Abstract] [Full Text] [Related]
55. Essentially pure murine interferon-alpha/beta primes poly rI:rC and Sendai virus-induced interferon production in mice.
Rosztóczy I; Megyeri K
J Biol Regul Homeost Agents; 1989; 3(1):35-8. PubMed ID: 2472043
[TBL] [Abstract][Full Text] [Related]
56. Adsorption of poly rI:rC on cell membrane participating and nonparticipating in interferon induction.
Yoshida I; Azuma M
J Interferon Res; 1985; 5(1):1-10. PubMed ID: 2580919
[TBL] [Abstract][Full Text] [Related]
57. Pharmacologic effects of polyinosinic-polycytidylic acid in man.
Freeman AI; Al-Bussam N; O'Malley JA; Stutzman L; Bjornsson S; Carter WA
J Med Virol; 1977; 1(2):79-93. PubMed ID: 347034
[TBL] [Abstract][Full Text] [Related]
58. In vivo release of previously cleared interferon by cycloheximide.
Chester TJ; De Clercq E; Nuwer MR; Merigan TC
Infect Immun; 1972 Mar; 5(3):383-8. PubMed ID: 4636292
[TBL] [Abstract][Full Text] [Related]
59. Purification and initial characterization of human placental trophoblast interferon induced by polyriboinosinic.polyribocytidylic acid.
Aboagye-Mathiesen G; Tóth FD; Juhl C; Nørskov-Lauritsen N; Petersen PM; Ebbesen P
J Gen Virol; 1990 Dec; 71 ( Pt 12)():3061-6. PubMed ID: 1703216
[TBL] [Abstract][Full Text] [Related]
60. Minimal interferon induction in dogs, using a modified polyriboinosinic-polyribocytidylic acid complex.
Smith JS; Yager PA; Baer GM
Am J Vet Res; 1980 Nov; 41(11):1833-5. PubMed ID: 6163381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
